Evolution of regional brain atrophy in children with multiple sclerosis
Gray matters
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
While multiple sclerosis (MS) has classically been considered to be a white matter disease, it is now clear that gray matter changes are seen at onset. Importantly, regional gray matter atrophy correlates strongly with motor outcomes in adult patients.1 Individuals with pediatric-onset MS have greater disease burden, as evidenced by higher relapse rate2 and increased lesion volume and atrophy on MRI3 than those with adult-onset MS. Furthermore, cognitive decline may be seen as early as 2 years after diagnosis in this population.4 Importantly, studies of structural correlates of disease progression in pediatric-onset MS must take the dynamic and maturational changes known to occur in the pediatric brain into account, including age- and sex-specific growth in some areas and regression and pruning in others.5 To this end, previous studies focused on white matter tracts and head size in pediatric-onset MS, and showed alterations in growth trajectories in patients with pediatric-onset MS in comparison with healthy youth.6 Others have demonstrated the extent of gray matter injury in the pediatric MS population, but have largely focused on specific deep gray matter structures.7 Much less is known about the dynamic pattern of growth and regression of various gray matter regions, and their relationship to outcomes in the pediatric patients with MS.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
See page 704
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Long-term disability progression of pediatric-onset multiple sclerosisKyla A. McKay, Jan Hillert, Ali Manouchehrinia et al.Neurology, May 15, 2019 -
Article
Dynamic gray matter volume changes in pediatric multiple sclerosisA 3.5 year MRI studyErmelinda De Meo, Alessandro Meani, Lucia Moiola et al.Neurology, March 13, 2019 -
Article
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelinationE. Daniëlle van Pelt, Julia Y. Mescheriakova, Nalia Makhani et al.Neurology, November 06, 2013 -
Article
Pediatric multiple sclerosisCognition and moodMaria Pia Amato, Lauren B. Krupp, Leigh E. Charvet et al.Neurology, August 29, 2016